Breaking News

Here's Why Investors Should Buy W.R. Berkley (WRB) Stock

By Zacks Investment ResearchSep 26, 2019 11:13PM ET
Here's Why Investors Should Buy W.R. Berkley (WRB) Stock
By Zacks Investment Research   |  Sep 26, 2019 11:13PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items

W.R. Berkley (NYSE:WRB) is well-poised for growth, given its sturdy insurance business, growing international business, sound capital position and prudent capital deployment.

Estimates for W.R. Berkley have been revised upward over the past 60 days, reflecting analysts’ confidence in the stock. The Zacks Consensus Estimate for 2019 earnings per share has moved 1.4% north while that for 2020 has moved up 0.7% in the said time frame. The company also has a solid track record of delivering positive earnings surprise in the last eight quarters, reflecting operational excellence.

Shares of W.R. Berkley have rallied 47.5% year to date, outperforming the industry’s increase of 6%.

This Zacks Rank #2 (Buy) property and casualty insurer’s return on equity was 10.6% in the trailing 12-month period, higher than the industry average of 6.8%. Return on equity is a profitability measure that identifies the company’s efficiency in utilizing its shareholders’ funds.

W.R. Berkley continues to expect growth from its insurance business, which contributed almost 89% of net premium written in the first half of 2019. Growth in insurance business has been driven by several new start-up units in varied business lines, supporting diversification benefits. Also, better pricing leads to premium growth.

Premium growth is also supported by its growing international business spread across United Kingdom, continental Europe, South America, Canada, Asia, Australia and Scandinavia.

The company’s investment income has been witnessing improvement driven by better-than-average performance of investment fund. It should continue to improve given the company’s investment in private equity fund and direct real estate opportunities.

W.R. Berkley’s solid balance sheet and steady cash flow aid it in efficient capital deployment. The company hikes dividend each year apart from paying out special dividend and buying back shares. In June 2019, the company approved a special dividend 50 cents (10th straight special dividend) and 10% hike in regular dividend, marking the 14th consecutive dividend hike. W.R. Berkley’s dividend yield of 0.6% betters the industry average of 0.4%, making it an attractive pick for yield-seeking investors.

The Zacks Consensus Estimate for 2019 and 2020 earnings per share is pegged at $2.86 and $2.92, indicating increase of nearly 7.1% and 2.1%, respectively from the year-ago reported figure. The expected long-term earnings growth rate is 9%. It has a favorable Growth Score of B. This style score identifies growth prospects of a company. Back-tested results show that stocks with Growth Score of A or B, combined with Zacks Rank #1 (Strong Buy) or 2, offer best growth opportunity.

Other Stocks to Consider

Some top-ranked stocks from the property and casualty insurance industry include Hallmark Financial Services (NASDAQ:HALL) , Palomar Holdings (NASDAQ:PLMR) , and RenaissanceRe Holdings (NYSE:RNR) each sporting a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Hallmark Financial underwrites markets, distributes and services property and casualty insurance products in the United States. The company came up with average four-quarter positive surprise of 97.50%.

Palomar Holdings provides personal and commercial specialty property insurance products. The company delivered average four-quarter positive surprise of 25.00%.

RenaissanceRe Holdings provides insurance and reinsurance products in the United States and internationally. The company pulled off an average four-quarter positive surprise of 141.77%.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

RenaissanceRe Holdings Ltd. (RNR): Free Stock Analysis Report

W.R. Berkley Corporation (WRB): Free Stock Analysis Report

Hallmark Financial Services, Inc. (HALL): Free Stock Analysis Report

Palomar Holdings, Inc. (PLMR): Free Stock Analysis Report

Original post

Zacks Investment Research
Here's Why Investors Should Buy W.R. Berkley (WRB) Stock
Here's Why Investors Should Buy W.R. Berkley (WRB) Stock

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email